| hRIO2 kinase ligand-1 |
HRIO2 激酶配体1 |
923841-73-0 |
| NLRP3-IN-22 |
NLRP3-IN-22 |
1193329-98-4 |
| Antiproliferative agent-41 |
Antiproliferative agent-41 |
225652-93-7 |
| Benzoic acid, 3-[[4-(1,1-dimethylethyl)phenyl]methoxy]- |
Benzoic acid, 3-[[4-(1,1-dimethylethyl)phenyl]methoxy]- |
228707-95-7 |
| 2-Chloro-N-[4-(2-fluorophenyl)-2-thiazolyl]acetamide |
化合物BAY 1892005 |
2036352-13-1 |
| 2-[[4-Chloro-3-(trifluoromethyl)phenyl]methylene]hydrazinecarboximidamide |
2-[[4-Chloro-3-(trifluoromethyl)phenyl]methylene]hydrazinecarboximidamide |
849459-88-7 |
| Hydrazinecarboximidamide, 2-[[4-chloro-3-(trifluoromethyl)phenyl]methylene]-, hydrochloride (1:1) |
AC-099 盐酸盐 |
849335-07-5 |
| eeAChE/eqBuChE-IN-1 |
eeAChE/eqBuChE-IN-1 |
2921654-26-2 |
| LSD1-IN-30 |
LSD1 抑制剂30 |
1289575-45-6 |
| 2-Naphthaleneacetamide, N-[3-[(methylamino)carbonyl]phenyl]- |
2-Naphthaleneacetamide, N-[3-[(methylamino)carbonyl]phenyl]- |
218936-13-1 |
| Carbamodithioic acid, N-(4-methyl-1-piperazinyl)-, potassium salt (1:1) |
Carbamodithioic acid, N-(4-methyl-1-piperazinyl)-, potassium salt (1:1) |
1358567-64-2 |
| (Z,E)-5-(4-ETHYLBENZYLIDINE)-2-THIOXOTHIAZOLIDIN-4-ONE |
5-(4-乙基苯亚甲基)绕丹宁 (该产品不可在美国销售) |
403811-55-2 |
| VU 0364439 |
N-[3-氯-4-[[(2-氯苯基)氨基]磺酰基]苯基]-2-吡啶甲酰胺 |
1246086-78-1 |
| VU 0364770 |
VU 0364770 |
61350-00-3 |
| VEGFR2 Kinase Inhibitor I |
VEGFR2 KISE INHIBITOR I |
15966-93-5 |
| UNC-926 Hydochloride |
UNC-926 |
1184136-10-4 |
| U0126-EtOH |
2,3-双[氨基[(2-氨基苯基)硫]亚甲基]丁二腈乙醇盐 |
1173097-76-1 |
| TYRPHOSTIN A48 |
TYRPHOSTIN A48 |
144978-82-5 |
| TYRPHOSTIN A9 |
酪氨酸磷酸化抑制剂A9 |
10537-47-0 |
| TYRPHOSTIN A25 |
酪氨酸磷酸化抑制剂25 |
118409-58-8 |
QQ
微信
